Integrative multi‐omics reveals the mechanism of ulcerative colitis treated with Ma‐Mu‐Ran antidiarrheal capsules
Rapid Communications in Mass Spectrometry · 2025
DOI: 10.1002/rcm.9939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2025. Verfasst von Hailing Huang und 15 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Metabolomics, Antidiarrheals, Gastrointestinal Microbiome. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Rationale
Ulcerative colitis (UC) is a chronic inflammatory gastrointestinal disease typically coexisting with intestinal microbiota dysbiosis, oxidative stress, and an inflammatory response. Although its underlying mechanism of action is unclear, Ma‐Mu‐Ran Antidiarrheal Capsules (MMRAC) have demonstrated significant therapeutic efficacy for UC.
Methods
The mechanism of action of MMRAC in the treatment of UC model was investigated by combining metabolomics, transcriptomics, and intestinal microbiota detection techniques.
Results
The high‐dose group of MMRAC was determined as the best therapeutic dose by pathological changes and biochemical indexes. Transcriptome analysis revealed that 360 genes were differentially altered after MMRAC treatment. Metabolomic analysis using colon tissue yielded 14 colon tissue metabolites with significant differences. Intestinal flora analysis showed that 26 major microorganisms were identified at the genus level.
Conclusions
Based on a thorough multi‐omics analysis of transcriptomics, metabolomics, and gut flora, it was determined that MMRAC regulated cysteine and methionine metabolism, arginine biosynthesis, and sphingolipid metabolism and their respective genes BHMT, PHGDH, iNOS, and SPHK1, which in turn served to inhibit UC‐generated inflammatory responses and oxidative stress. Additionally, MMRAC regulated the abundance of Coprococcus, Helicobacter, Sutterella, Paraprevotella, and Roseburia in the intestinal tracts of UC mice, which was regulated toward normal levels, thereby restoring normal intestinal function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
- Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, China.
- College of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
- Key Laboratory of Chinese Medicine Resources and Compound Chinese Medicine, Ministry of Education, Hubei University of Chinese Medicine, Wuhan, China.
ORCID-Profile: Hailing Huang
Zitieren
APA
Huang, H., Duan, B., Huang, Z., Wang, S., Wen, Y., Jiang, Q., Chen, P., Huang, P., Liu, J., Zheng, S., Ye, Y., Zhang, D., Wang, Q., Huang, F., Li, J., & Han, L. (2025). Integrative multi‐omics reveals the mechanism of ulcerative colitis treated with Ma‐Mu‐Ran antidiarrheal capsules. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9939
Vancouver
Huang H, Duan B, Huang Z, Wang S, Wen Y, Jiang Q, et al. Integrative multi‐omics reveals the mechanism of ulcerative colitis treated with Ma‐Mu‐Ran antidiarrheal capsules. Rapid Communications in Mass Spectrometry. 2025. doi:10.1002/rcm.9939
BibTeX
@article{Huang2025,
author = {Huang, Hailing and Duan, Bailu and Huang, Zhuang and Wang, Shanshan and Wen, Yuxin and Jiang, Qi and Chen, Pengyu and Huang, Ping and Liu, Jiajing and Zheng, Sili and Ye, Yan and Zhang, Dongning and Wang, Qiong and Huang, Fang and Li, Jingjing and Han, Lintao},
title = {Integrative multi‐omics reveals the mechanism of ulcerative colitis treated with Ma‐Mu‐Ran antidiarrheal capsules},
journal = {Rapid Communications in Mass Spectrometry},
year = {2025},
doi = {10.1002/rcm.9939}
}
EUVIMED